News › Industry News, News

Revance Announces U.S. Distribution Deal for Dermal Fillers from Teoxane SA

January 13, 2020

Revance Therapeutics, Inc., a biotechnology company searching for new innovations in neuromodulators for aesthetic and therapeutic indications, has announced the signing of a U.S. distribution agreement with Teoxane SA, making Revance the exclusive commercialization partner of the Swiss company’s Resilient Hyaluronic Acid (RHA) technology.
Read more from Revance >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • AmSpa’s Medical Spa Show Voted Best Tradeshow Injectable Education
    • Ohio Med Spa Fined $25,000 Following Prescription Drug Violations Investigation
    • Mississippi Boards Warn Against Use of ‘Research-Grade’ Peptides
    • Weave Supports AmSpa Members as Platinum Vendor Affiliate
    • Allergan Aesthetics Says the Future of Aesthetics Is Layered
Advertisement